CLINICAL PHARMACOKINETICS OF KETOCONAZOLE

被引：184

作者：

DANESHMEND, TK ^{[1
]}

WARNOCK, DW ^{[1
]}

机构：

[1] BRISTOL ROYAL INFIRM, DEPT MICROBIOL, BRISTOL BS2 8HW, AVON, ENGLAND

来源：

CLINICAL PHARMACOKINETICS | 1988年 / 14卷 / 01期

关键词：

D O I：

10.2165/00003088-198814010-00002

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：13 / 34

页数：22

共 138 条

[71] PHARMACOKINETICS AND DOSE PROPORTIONALITY OF KETOCONAZOLE IN NORMAL VOLUNTEERS [J].

HUANG, YC ;

COLAIZZI, JL ;

BIERMAN, RH ;

WOESTENBORGHS, R ;

HEYKANTS, J .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 30 (02) :206-210

[72] KETOCONAZOLE [J].

HUME, AL ;

KERKERING, TM .

DRUG INTELLIGENCE & CLINICAL PHARMACY, 1983, 17 (03) :169-174

[73] ORAL KETOCONAZOLE THERAPY FOR KERATOMYCOSIS [J].

ISHIBASHI, Y .

AMERICAN JOURNAL OF OPHTHALMOLOGY, 1983, 95 (03) :342-345

[74]

Janssen P A, 1983, Am J Med, V74, P80, DOI 10.1016/0002-9343(83)90519-3

[75]

JOHNSON R, 1985, PERITON DIALYSIS B, V5, P136

[76] KETOCONAZOLE KINETICS IN CHRONIC PERITONEAL-DIALYSIS [J].

JOHNSON, RJ ;

BLAIR, AD ;

AHMAD, S .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1985, 37 (03) :325-329

[77]

JONES HE, 1981, ARCH DERMATOL, V117, P129, DOI 10.1001/archderm.117.3.129

[78] EFFICACY OF KETOCONAZOLE V NYSTATIN IN PREVENTION OF FUNGAL-INFECTIONS IN NEUTROPENIC PATIENTS [J].

JONES, PG ;

KAUFFMAN, CA ;

MCAULIFFE, LS ;

LIEPMAN, MK ;

BERGMAN, AG .

ARCHIVES OF INTERNAL MEDICINE, 1984, 144 (03) :549-551

[79]

JORGENSEN JH, 1981, ANTIMICROB AGENTS CH, V20, P59, DOI 10.1128/AAC.20.1.59

[80] FUNGAL PERITONITIS IN PATIENTS ON CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS [J].

KERR, CM ;

PERFECT, JR ;

CRAVEN, PC ;

JORGENSEN, JH ;

DRUTZ, DJ ;

SHELBURNE, JD ;

GALLIS, HA ;

GUTMAN, RA .

ANNALS OF INTERNAL MEDICINE, 1983, 99 (03) :334-337

← 3 4 5 6 7 8 9 10 11 12 →